% | $
Quotes you view appear here for quick access.

Immune Pharmaceuticals, Inc. Message Board

  • vkstudti vkstudti Apr 10, 2007 8:46 AM Flag


    Lets say that NP-1 gets approved, azixa gets approved, and ceplene (god willing) gets approved...long shots all except azixa, but we can hope

    annual sales (VERY CONSERVATIVELY)

    NP-1 $200M (they think $1B so i take 20%)
    ceplene $100M (they think $200M so i take 50%)
    azixa $100M (mygn says $1B and we get ~10%)

    by my crude math that is $400M in sales with expenditures of $75M last year (not gonna happen every year!!!!) we have earnings of $325M on like 50M shares already diluted and no need for further money...uhm??? earnings of like $7.50 a share with a PE of 10 gives us how much in the s/p????


0.21-0.02(-6.67%)May 26 4:00 PMEDT